AdventHealth Altamonte Springs

Clinical research site in Altamonte Springs, Florida · 831 S STATE ROAD 434, ALTAMONTE SPRINGS, FL 32714-3560 · (407) 587-8600

As of July 2026, 5 paid clinical trials are recruiting at AdventHealth Altamonte Springs in Altamonte Springs, Florida. Active studies at this site cover conditions such as Breast Neoplasms, Early Breast Cancer and Neoplasm Metastasis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at AdventHealth Altamonte Springs (5)

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

for Breast Neoplasms

28 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: Female·Age: 18+

Code: NCT07287098·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for Breast Neoplasms

116 locations incl. Anchorage

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for Early Breast Cancer

85 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for Triple-Negative Breast Cancer

81 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06393374·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for Breast Neoplasms

42 locations incl. Chandler

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06312176·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

More research sites in Altamonte Springs

AdventHealth Altamonte (6 trials)
Florida Eye Clinic (3 trials)
AdventHealth Medical Group Oncology and Hematology at Altamonte (3 trials)
Neurology of Central FL Res Ctr (2 trials)
Neurology of Central Florida Research Center, LLC (2 trials)
Advanced Asc (1 trial)
Advent Health Orlando (1 trial)
AdventHealth (1 trial)
AdventHealth East Altamonte Oncology and Hematology (1 trial)
Anthos Investigative (1 trial)

Explore more

Paid clinical trials in Altamonte Springs, FL · Florida clinical trials